Impact of educational interventions on adverse drug events reporting

International Journal of Technology Assessment in Health Care

Volumn 29, Issue 4, 2013, Pages 410-417

  Pagotto, Caroline ^a   Varallo, Fabiana ^a   Mastroianni, Patrícia ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

adverse drug reaction reporting systems; attitudes; education continuing; educational intervention; health knowledge; pharmacovigilance; practice

Indexed keywords

EDUCATION; HEALTH;

ATTITUDES; EDUCATIONAL INTERVENTION; PHARMACOVIGILANCE; PRACTICE; REPORTING SYSTEMS;

PHARMACODYNAMICS;

ADVERSE DRUG REACTION; ARTICLE; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; E-MAIL; GROUP DYNAMICS; HEALTH EDUCATION; HEALTH PRACTITIONER; HUMAN; INTERVIEW; LONGITUDINAL STUDY; MEDICATION ERROR; META ANALYSIS; OBSERVATIONAL STUDY; QUASI EXPERIMENTAL STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE DATABASE; SYSTEMATIC REVIEW; TIME SERIES ANALYSIS; WORKSHOP; CLINICAL PRACTICE; CONTINUING EDUCATION; EDUCATION; HEALTH PERSONNEL ATTITUDE; MEDICAL STAFF; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; STATISTICS AND NUMERICAL DATA;

ATTITUDE OF HEALTH PERSONNEL; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EDUCATION, CONTINUING; GUIDELINE ADHERENCE; HUMANS; MEDICAL STAFF, HOSPITAL; PHARMACOVIGILANCE; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL PRACTICE;

EID: 84889577323     PISSN: 02664623     EISSN: 14716348     Source Type: Journal    
DOI: 10.1017/S0266462313000457     Document Type: Article

References (39)

1. Leendertse AJ, Visser D, Egberts AC, van den Bemt PM. The relationship between study characteristics and the prevalence of medicationrelated hospitalizations: A literature review and novel analysis. Drug Saf. 2010;33:233-244.
2. Dequiro AB, Mol PG, van Doormaal JE, et al. Preventable and nonpreventable adverse drug events in hospitalized patients: A prospective chart review in the Netherland. Drug Saf. 2011;34:1089-1100.
3. Hazell L, Shaki SA. Under-reporting of adverse drug reactions: A systematic review. Drug Saf. 2006;29:385-386.
4. Ribeiro-Vaz I, Herdeiro MT, Poĺonia J, Figueiras A. Strategies to increase the sensitivity of pharmacovigilance in Portugal. Rev Saude Publica. 2011;45:129-135.
5. Meyboom RH, EgbertsAC, Gribnau FW, HeksterYA. Pharmacovigilance in Perspective. Drug Saf. 1999;21:429-447.
6. Conforti A, Opri S, D'Incau P, et al. Adverse drug reaction reporting by nurses: Analysis of Italian pharmacovigilance database. Pharmacoepidemiol Drug Saf. 2012;21:597-602.
7. Gedde-Dahl A, Harg P, Stenberg-Nilsen H, et al. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway. Pharmacoepidemiol Drug Saf. 2007;16:999-1005.
8. OPS. Buenas Pŕacticas de Farmacovigilancia para las Aḿericas. Washington, DC: OPS,-c 2010. (Red PARF Documento Técnico No. 5). 78 ṕag.
9. Forsetlund L, Bjorndal A, Rashidian A, et al. Continuing Educationmeeting and workshops: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2009;15:CD00303.
10. Ĺopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of underreporting of adverse drug reactions: A systematic review. Drug Saf. 2009;32:19-31.
11. Molokhia M, Tanna S, Bell D. Improving reporting of adverse drug reactions: Systematic review. Clin Epidemiol. 2009;1:75-92.
12. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol. 2009;62:1006-1012.
13. Herdeiro MT, Ribeiro-Vaz I, Ferreira M, et al.Workshop-and telephonebased interventions to improve adverse drug reaction reporting: A clusterrandomized trial in Portugal. Drug Saf. 2012;35:655-665.
14. Cereza G, Agust́? A, Pedŕos C, et al. Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital. Eur J Clin Pharmacol. 2010;66:937-945.
15. Gony M, Badie K, Sommet A, et al. Improving adverse drug reaction reporting in hospitals results of the French pharmacovigilance in Midi-Pyŕeńees Region (PharmacoMIP) Network 2-Year Pilot Study. Drug Saf. 2010;33:409-416.
16. Pedŕos C, Vallano A, Cereza G, et al. An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: A time series analysis in Spain. Drug Saf. 2009;32:77-83.
17. Herdeiro MT, Poĺonia J, Gestal-Otero JJ, Figueiras A. Improving the reporting of adverse drug reactions. A cluster-randomized trial among pharmacists in Portugal. Drug Saf. 2008;31:335-344.
18. Figueiras A, Herdeiro MT, Poĺonia J, Gestal-Otero JJ. An educational intervention to improve physician reporting of adverse drug reactions. A cluster-randomized controlled trial. JAMA. 2006;296:1086-1093.
19. Bracchi RC, Houghton J,Woods FJ, et al. Adistance-learning programme in pharmacovigilance linked to educational credits is associated with improved reporting of suspected adverse drug reactions via theUKyellow card scheme. Br J Clin Pharmacol. 2005;60:221-223.
20. Backstr̈om M, Mjorndal T, Dahlqvist R. Spontaneous reporting of adverse drug reactions by nurses. Pharmacoepidemiol Drug Saf. 2002;11:647-650.
21. Clarkson A, Ingleby E, Choonara I, Bryan P, Arlett P. A novel scheme for the reporting of adverse drug reactions. Arch Dis Child. 2001;84:337-339.
22. McGettigan P, Golden J, Conroy RM, Arthur N, Feely J. Reporting of adverse drug reaction by hospital doctors and the response to intervention. Br J Clin Pharmacol. 1997;44:98-100.
23. Scott HD, Thacher-Renshaw A, Rosenbaum SE, et al. Physician reporting of adverse drug reaction. Results of the Rhode Island adverse drug reaction reporting project. JAMA. 1990;263:1785-1788.
24. Biagi C, Montanaro N, Buccellato E, et al. Underreporting in pharmacovigilance: An intervention for Italian GPs (Emilia-Romagna region). Eur J Clin Pharmacol. 2013;69:237-244.
25. Primo LP, Capucho HC. Intervenç ̃oes educativas para est́?mulo a notificaç ̃oes volunt́arias em um hospital de ensino da rede sentinela. Rev Bras Farm Hosp Serv. 2011;2:26-30.
26. JohanssonML, Ḧagg S,Wallerstedt SM. Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: A randomized controlled study. BMC Clin Pharmacol. 2011;11:14-19.
27. JohanssonML, Brunl̈of G, Edward C,Wallerstedt SM. Effects of e-mails containing ADR information and a current case report on ADR reporting rate and quality of reports. Eur J Clin Pharmacol. 2009;65:511-514.
28. Gerritsen R, Faddegon H, Dijkers F, van Grootheest K, van Puijenbroek E. Effectiveness of pharmacovigilance training of general practitioners: A retrospective cohort study in the Netherlands comparing two methods. Drug Saf. 201;34:755-762.
29. Baniasadi S, Fahimi F, Shalviri G. Developing an adverse drug reaction reporting system at a teaching hospital. Basic Clin Pharmacol Toxicol. 2008;102:408-411.
30. B̈ackstr̈om M, Ekman E,Mj̈orndal T. Adverse drug reaction reporting by nurses in Sweden. Eur J Clin Pharmacol. 2007;63:613-618.
31. Durrieu G, Hurault C, Bongard V, Damase-Michel C, Montastruc JL. Perception of risk of adverse drug reactions by medical students: Influence of 1 year pharmacological course. Br JClin Pharmacol. 2007;64:233-236.
32. Granas AG, Buajordet M, Stenberg-Nilsen H, Harg P, Horn AM. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway. Pharmacoepidemiol Drug Saf. 2007;16:429-434.
33. B̈ackstr̈om M, Mj̈orndal T. A small economic inducement to stimulate increased reporting of adverse drug reactions-A way of dealing with an old problem? Eur J Clin Pharmacol. 2006;62:381-385.
34. Cox AR, Marriott JF, Wilson KA, Ferner RE. Adverse drug reaction teaching in UK undergraduate medical and programmes. J Clin Pharm Ther. 2004;29:31-35.
35. Rosebraugh CJ, Tsong Y, Zhou F, et al. Improving the quality of adverse drug reaction reporting by 4th-year medical students. Pharmacoepidemiol Drug Saf. 2003;12:97-101.
36. Morrison-Griffiths S, Walley TJ, Park BK, Breckenridge AM, Pirmohamed M. Reporting of adverse drug reactions by nurses. Lancet. 2003;361:1347-1348.
37. Goldman SA. Use of a mail-out continuing education article to teach health professionals about drug-induced disease. J Clin Pharmacol. 1999;39:1126-1135.
38. Zolezzi M, Parsotam N. Adverse drug reaction reporting in New Zealand: Implications for pharmacists. Ther Clin Risk Manag. 2005;1:181-188.
39. GrootheestK,Olsson S, CouperM, de Jong-van den Berg L. Pharmacists' role in reporting adverse drug reactions in an international perspective. Pharmacoepidemiol Drug Saf. 2004;13:457-464.